Kirsten Nagashima

HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5

Tatjana Dragic, Virginia Litwin, Graham P. Allaway et al. · Nature · 1996 · 3.2K citations

Life Sciences, Immunology, Molecular Biology +14

AMD3100, a small molecule inhibitor of HIV-1 entry via the CXCR4 co-receptor

G A Donzella, Dominique Schols, Steven Lin et al. · Nature Medicine · 1998 · 763 citations

Medicine, Medicinal Chemistry, Pharmacology +15

Dual blockade of IL‐4 and IL‐13 with dupilumab, an IL‐4Rα antibody, is required to broadly inhibit type 2 inflammation

Audrey Le Floc’h, Jeanne Allinne, Kirsten Nagashima et al. · Allergy · 2019 · 490 citations · Full text

Medicine, Immunology, Pharmacology +17

Differential Inhibition of Human Immunodeficiency Virus Type 1 Fusion, gp120 Binding, and CC-Chemokine Activity by Monoclonal Antibodies to CCR5

William C. Olson, Gwénaël Rabut, Kirsten Nagashima et al. · Journal of Virology · 1999 · 226 citations · Full text

Life Sciences, Immunology, Molecular Biology +11

Potent, Broad-Spectrum Inhibition of Human Immunodeficiency Virus Type 1 by the CCR5 Monoclonal Antibody PRO 140

Alexandra Trkola, Thomas J. Ketas, Kirsten Nagashima et al. · Journal of Virology · 2001 · 225 citations · Full text

Pharmacy, Immunology, Pharmacology +11